Carson Wealth (CWM LLC)
INBX icon

Carson Wealth (CWM LLC)’s Inhibrx INBX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7K Buy
159
+4
+3% +$297 ﹤0.01% 4750
2025
Q4 		$12K Buy
155
+7
+5% +$477 ﹤0.01% 4457
2025
Q3 		$5K Buy
148
+23
+18% +$566 ﹤0.01% 4730
2025
Q2 		$2K Sell
125
-36
-22% -$465 ﹤0.01% 4888
2025
Q1 		$2K Sell
161
-82
-34% -$1.11K ﹤0.01% 4766
2024
Q4 		$4K Sell
243
-306
-56% -$4.66K ﹤0.01% 4315
2024
Q3 		$9K Buy
+549
New +$7.71K ﹤0.01% 3832

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Carson Wealth (CWM LLC)'s INBX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Inhibrx (INBX) stake by 2.6% in Q1 2026, buying an estimated $297 and bringing the position to 159 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4750.

Carson Wealth (CWM LLC) first reported a position in INBX in Q3 2024 and has held it in 7 quarters since. The position peaked at $12K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 159 shares of Inhibrx worth $10.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 4 Inhibrx shares in Q1 2026, an estimated $297.
  • Inhibrx made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4750 holding.
  • Carson Wealth (CWM LLC) first reported a position in Inhibrx in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s Inhibrx position peaked at $12K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.